展開選單
About Us
Company
Milestones
Awards & Recognitions
Our Team
News
Clinical Pipeline
Contact
搜尋
繁中
EN
收合選單
搜尋
EN
繁體中文
English
HOME
News
News
Jul 07, 2022
GoldenBiotech Received FDA AoR of its Pre-EUA Meeting Request for COVID-19 Trial Drug Antroquinonol
May 27, 2022
FDA Approves GoldenBiotech’s IND Application of Antroquinonol for Phase II Trial on Relapsed Acute Myeloid Leukemia (AML)
Jan 05, 2022
TIME News: 100% Recovery-GoldenBiotech Announces Topline Results from Unblinded COVID-19 Trial for Oral New Drug Antroquinonol in Hospitalized Mild, Moderate and Severe Patients
Aug 30, 2021
COVID-19 Scoop: Epoch-Making GoldenBiotech’s Oral COVID-19 New Drug Trial of Antroquinonol Got Green Light from the FDA to Extend Recruiting Severe COVID-19 Patients
Aug 25, 2021
國鼎生技與奧地利Sanova Pharma 簽署新冠肺炎新藥在歐洲23國的合作備忘錄
Jul 02, 2021
GoldenBiotech Antroquinonol Granted Compassionate Use in Taiwan for Treating Covid-19 Patients
Jun 03, 2021
Covid-19 Trial: GoldenBiotech New Drug Antroquinonol Passed 2nd DMC Review in the USA
May 27, 2021
國鼎生技血癌二期臨床結果論文摘要榮獲ASCO審查通過於大會官網發表
Apr 19, 2021
GoldenBiotech Completes Second Interim of Patients Enrollment for Covid-19 Phase 2 Clinical Trial
Apr 07, 2021
GoldenBiotech Presents Outstanding Results of Potential Treatment for Relapsed AML in ASCO 2021
Feb 26, 2021
國鼎生技收到BNC Korea Co., Ltd.依約支付新冠肺炎(Covid-19)新藥授權之第二期簽約金200萬美元
Jan 16, 2021
Covid-19 Drug Duo Achievements: GoldenBiotech’s New Drug Antroquinonol (HOCENA) Trial Receives Positive Response from DMC Review and Licenses for 4 Countries
上一頁
1
2
下一頁